248 related articles for article (PubMed ID: 30837335)
1. A Novel
Spurgeon ME; Uberoi A; McGregor SM; Wei T; Ward-Shaw E; Lambert PF
mBio; 2019 Mar; 10(2):. PubMed ID: 30837335
[TBL] [Abstract][Full Text] [Related]
2. Key aspects of papillomavirus infection influence the host cervicovaginal microbiome in a preclinical murine papillomavirus (MmuPV1) infection model.
Spurgeon ME; Townsend EC; Blaine-Sauer S; McGregor SM; Horswill M; den Boon JA; Ahlquist P; Kalan L; Lambert PF
mBio; 2024 May; ():e0093324. PubMed ID: 38742830
[TBL] [Abstract][Full Text] [Related]
3. A Novel Model for Papillomavirus-Mediated Anal Disease and Cancer Using the Mouse Papillomavirus.
Blaine-Sauer S; Shin MK; Matkowskyj KA; Ward-Shaw E; Lambert PF
mBio; 2021 Aug; 12(4):e0161121. PubMed ID: 34281391
[TBL] [Abstract][Full Text] [Related]
4. An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer.
Wei T; Buehler D; Ward-Shaw E; Lambert PF
mBio; 2020 May; 11(3):. PubMed ID: 32398315
[TBL] [Abstract][Full Text] [Related]
5. Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
Wang W; Spurgeon ME; Pope A; McGregor S; Ward-Shaw E; Gronski E; Lambert PF
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2214225120. PubMed ID: 36917668
[TBL] [Abstract][Full Text] [Related]
6. Role of Ultraviolet Radiation in Papillomavirus-Induced Disease.
Uberoi A; Yoshida S; Frazer IH; Pitot HC; Lambert PF
PLoS Pathog; 2016 May; 12(5):e1005664. PubMed ID: 27244228
[TBL] [Abstract][Full Text] [Related]
7. Sexual transmission of murine papillomavirus (MmuPV1) in
Spurgeon ME; Lambert PF
Elife; 2019 Oct; 8():. PubMed ID: 31621578
[TBL] [Abstract][Full Text] [Related]
8. The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
Antiviral Res; 2023 Aug; 216():105667. PubMed ID: 37429527
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
10. Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).
Uberoi A; Yoshida S; Lambert PF
J Virol Methods; 2018 Mar; 253():11-17. PubMed ID: 29253496
[TBL] [Abstract][Full Text] [Related]
11. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.
Torres AD; Spurgeon ME; Bilger A; Blaine-Sauer S; Uberoi A; Buehler D; McGregor SM; Ward-Shaw E; Lambert PF
Virology; 2020 Feb; 541():1-12. PubMed ID: 31826841
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
bioRxiv; 2023 Apr; ():. PubMed ID: 36993217
[TBL] [Abstract][Full Text] [Related]
14. MmuPV1 E7's interaction with PTPN14 delays Epithelial differentiation and contributes to virus-induced skin disease.
Romero-Masters JC; Grace M; Lee D; Lei J; DePamphilis M; Buehler D; Hu R; Ward-Shaw E; Blaine-Sauer S; Lavoie N; White EA; Munger K; Lambert PF
PLoS Pathog; 2023 Apr; 19(4):e1011215. PubMed ID: 37036883
[TBL] [Abstract][Full Text] [Related]
15. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
16. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.
Gunder LC; Blaine-Sauer S; Johnson HR; Shin MK; Auyeung AS; Zhang W; Leverson GE; Ward-Shaw ET; King RE; McGregor SM; Matkowskyj KA; Lambert PF; Carchman EH
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893697
[TBL] [Abstract][Full Text] [Related]
19. The environmental pollutant and tobacco smoke constituent dibenzo[def,p]chrysene is a co-factor for malignant progression of mouse oral papillomavirus infections.
Christensen ND; Chen KM; Hu J; Stairs DB; Sun YW; Aliaga C; Balogh KK; Atkins H; Shearer D; Li J; Brendle SA; Gowda K; Amin S; Walter V; Viscidi R; El-Bayoumy K
Chem Biol Interact; 2021 Jan; 333():109321. PubMed ID: 33186600
[TBL] [Abstract][Full Text] [Related]
20. Role of IQGAP1 in Papillomavirus-Associated Head and Neck Tumorigenesis.
Wei T; Choi S; Buehler D; Lee D; Ward-Shaw E; Anderson RA; Lambert PF
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
